metaMe Health Named to the 2022 CB Insights Digital Health Top 150 List
CHICAGO, December 9, 2022 – metaMe Health breaks into the top 150 of the most promising private digital health companies of 2022. By being recognized… Read more
Gut Directed Hypnosis and IBS Management
Listen to UNC-Chapel Hill’s Dr. Olafur Palsson, originator of the gold-standard North Carolina treatment protocol for gut-directed hypnotherapy (GDH)… Read more
Digital Health Today
Hear metaMe Health CEO Tim Rudolphi discuss the founding story of our company, the impact of gut-directed hypnotherapy, and the commercialization of PDTs.
Listen… Read more
Gut-Brain Connect: How metaMe’s Digital Therapeutic Hopes To Rewire IBS Treatment
metaMe Health CEO and ex-Takeda executive Tim Rudolphi and partner firm Indegene’s senior vice president Marut Setia discuss with Scrip plans for the… Read more
metaMe Health partners with Indegene to launch Regulora®, an FDA-cleared Prescription Digital Therapeutic for adults with Irritable Bowel Syndrome
Princeton, NJ, and Chicago, IL, United States, March 22, 2022 – Indegene, a technology-led global healthcare solutions provider, and metaMe Health… Read more
metaMe Health Raises $2.2 Million to Bring Its IBS Solution to Market
The launch of ReguloraⓇ will provide accessible pain relief to the 10-15% of U.S. adults who live with IBS
CHICAGO… Read more